Scholarly Index
Gunilla Olivecrona
Lipigon Pharmaceuticals (Sweden); 10,619 total citations; 212 total publications; best world rank #142
Lipigon Pharmaceuticals (Sweden)
10,619Total citations
212Total publications
59H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Lipid metabolism and disorders | Lifetime | 142 | SE 8 | 98.18 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 409 | SE 12 | 98.60 |
| Cancer, Lipids, and Metabolism | Lifetime | 959 | SE 23 | 96.71 |
| Lipoproteins and Cardiovascular Health | Lifetime | 943 | SE 23 | 96.51 |
| Lipid metabolism and biosynthesis | Lifetime | 796 | SE 27 | 94.09 |
| Lipid metabolism and disorders | 2021-2025 | 556 | SE 10 | 69.39 |